Drug Rehab: Inpatient vs Outpatient Programs, Costs, and Success Rates
Compare inpatient and outpatient drug rehab programs by cost, structure, and success rates. Learn which program type fits different addiction severity levels.
21 Million Americans Need Addiction Treatment; Only 10% Receive It
The 2023 National Survey on Drug Use and Health reported that 21.9 million Americans aged 12 and older needed substance use treatment but did not receive it. Of those who did receive treatment, the type of program — inpatient residential versus various outpatient formats — varied dramatically based on insurance coverage, geographic availability, and addiction severity. The economic cost of drug addiction in the United States, including healthcare, lost productivity, criminal justice costs, and social welfare, exceeds $740 billion annually according to the National Institute on Drug Abuse.
Inpatient Residential Programs
Inpatient treatment provides 24-hour supervision in a live-in facility. Standard residential programs run 28–30 days, though longer-term therapeutic communities may span 6–12 months. The residential environment removes patients from environments and relationships associated with drug use — a meaningful advantage for individuals in high-risk living situations.
Short-term residential programs (28–30 days) follow a structured daily schedule including individual counseling, group therapy, psychoeducation, 12-step meetings, and life skills programming. Medically managed detoxification, if required, typically occurs in the first three to seven days. After the residential phase, patients are ordinarily stepped down to intensive outpatient or standard outpatient continuing care.
- 28-day program: Most common insurance-covered duration; intensive structured programming
- 60-day program: Allows deeper therapeutic work; recommended for patients with multiple prior treatment failures
- 90-day program: NIDA research associates 90+ days as threshold for significantly improved outcomes
- Long-term therapeutic community (6–12 months): Hierarchical peer community model; most evidence-based for severe, chronic addiction
Outpatient Program Types
Outpatient treatment encompasses a spectrum of service intensities. The critical distinction is whether the patient returns home each day or remains in a supervised residential environment.
| Program Type | Hours per Week | Typical Schedule | Best For |
|---|---|---|---|
| Standard Outpatient | 1–8 hours | 1–2 sessions/week | Mild SUD; continuing care after residential |
| Intensive Outpatient (IOP) | 9–19 hours | 3–5 days/week, 3 hrs/session | Moderate SUD; stable housing and support |
| Partial Hospitalization (PHP) | 20–30 hours | 5 days/week, 4–6 hrs/day | Moderate-severe SUD; step-down from inpatient |
Intensive outpatient programs have grown substantially since the mid-2000s, partly because they cost significantly less than inpatient treatment and allow patients to maintain employment and family responsibilities. Multiple systematic reviews have found comparable outcomes between IOP and inpatient treatment for patients who are appropriately matched — that is, those without severe withdrawal risk, co-occurring psychiatric illness, or unsafe home environments.
Cost Comparison
| Program Type | Average Cost (30 days) | Insurance Coverage |
|---|---|---|
| Standard outpatient | $1,000 – $5,000 | Typically covered as mental health benefit |
| IOP | $3,000 – $15,000 | Covered; prior auth often required |
| PHP | $7,000 – $20,000 | Covered; strict medical necessity criteria |
| Standard residential (28 days) | $5,000 – $30,000 | Covered; length-of-stay limits common |
| Long-term residential (90 days) | $12,000 – $60,000 | Partial coverage; varies widely |
| Luxury residential (30 days) | $30,000 – $100,000+ | Mostly self-pay; amenities not covered |
Success Rates and What They Actually Measure
Addiction treatment "success rates" are notoriously difficult to compare across programs because definitions vary. Common metrics include 30-day abstinence, 12-month abstinence, treatment completion, reduction in drug use (harm reduction), and quality-of-life measures. Relapse rates are high across all treatment modalities: NIDA reports that 40–60% of people treated for addiction relapse at some point, comparable to relapse rates in other chronic conditions like hypertension and asthma.
Relapse is not treatment failure. The chronic disease model of addiction treats return to use as a signal for treatment adjustment, not evidence that treatment is futile. Patients who complete 90 or more days of treatment have substantially better outcomes than those who complete 30 days. A landmark 2016 study in JAMA Psychiatry found that each additional month of medication-assisted treatment with buprenorphine reduced six-month opioid use probability by approximately 11 percentage points.
- Treatment completion: Only 40–50% of inpatient patients complete the full program; dropout is the strongest predictor of relapse
- 12-month abstinence (opioid MAT): 40–60% of patients on buprenorphine maintenance; lower without medication
- Long-term recovery: Duration of recovery increases probability of sustained remission; after 5 years of abstinence, relapse risk drops substantially
Which Program Is Right for Whom
Clinical placement criteria from the American Society of Addiction Medicine (ASAM) guide matching decisions. Several evidence-based factors support inpatient over outpatient placement: history of multiple outpatient treatment failures, severe or unpredictable withdrawal risk, co-occurring psychiatric disorders requiring 24-hour supervision, unstable or drug-saturated living environment, lack of social support, and high relapse potential in the current environment.
Conversely, patients with strong social support, stable employment, mild-to-moderate addiction severity, and no prior treatment failures are appropriate candidates for IOP as a first intervention. The most effective approach combines the appropriate program level with FDA-approved medications where indicated (methadone, buprenorphine for opioid use disorder; naltrexone for opioid and alcohol use disorder) and long-term continuing care engagement.
This article is for informational purposes only. Consult a qualified healthcare professional before making medical decisions.
Related Articles
mental health
Acceptance and Commitment Therapy: Psychological Flexibility Over Symptom Removal
ACT is a third-wave behavioral therapy developed by Steven Hayes in 1986 that prioritizes psychological flexibility and valued living over symptom elimination.
9 min read
mental health
Alcohol Rehab Costs and Insurance: What Treatment Actually Covers
Alcohol rehab costs range from $0 (free programs) to $80,000+ for luxury residential. Learn what insurance, Medicaid, and Medicare cover and how to reduce costs.
9 min read
mental health
Anxiety vs Anxiety Disorder: When Normal Worry Becomes a Medical Condition
Anxiety is a universal human experience, but anxiety disorders are distinct medical conditions that require treatment. This guide explains the line between normal anxiety and clinical disorder, the main types of anxiety disorders, their causes, and the treatments that are most effective.
11 min read
mental health
Eating Disorder Treatment Options: Programs, Costs, and Insurance
Eating disorders have the highest mortality of any psychiatric condition. Learn about treatment levels, costs ranging $500–$2,000 per day, and insurance coverage.
9 min read